跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
RITUXAN SC - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
RITUXAN SC
Authorized
STANDARD
RITUXAN SC
Hoffmann-La Roche Limited
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
354bcac38f6d9ddb
Company
Hoffmann-La Roche Limited
Type
Standard
Approval Details
Approval Id
354bcac38f6d9ddb
Drug Approval Canada Name
RITUXAN SC
Product Name
RITUXAN SC
Status
Marketed
Status Date
2018-04-24
Original Market Date
2018-04-24
Din
02473976
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Subcutaneous
Schedule
Prescription , Schedule D
Ahfs
10:00.00
Atc Original
L01FA01 RITUXIMAB
Atc Name
l 01 fa 01
Aig Number
0140241002
Company Name
Hoffmann-La Roche Limited
Company Address
7070 Mississauga Road, Mississauga, Ontario, Canada, L5N 5M8
Active Ingredients
RITUXIMAB
1600 MG / 13.4 ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
354bcac38f6d9ddb
Type
Standard
Back to Health Canada Approvals